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A PILOT RANDOMIZED CONTROLLED TRIAL OF
COGNITIVE BEHAVIORAL THERAPY FOR PERINATAL
DEPRESSION ADAPTED FOR WOMENWITH LOW
INCOMES
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Background: Perinatal women with identified depression in prenatal care set-
tings have low rates of engagement and adherence with depression-specific
psychotherapy. We report the feasibility and symptom outcomes of Cognitive
Behavioral Therapy (CBT) modified (mCBT) to address the needs of perinatal,
low-income women with Major Depressive Disorder (MDD). Methods: Preg-
nant women (n = 1421) were screened for depressive symptoms in obstetrics
clinics in conjunction with prenatal care visits. A total of 59 women met di-
agnostic criteria for MDD; 55 women were randomly assigned to mCBT or
Treatment as Usual (TAU). The mCBT intervention included an initial en-
gagement session, outreach, specific perinatal content and interpersonal compo-
nents. Measures were gathered at pre-treatment, 16 week post-randomization,
and 3-month follow-up. Results: Most participants attended at least one CBT
session and met study criteria for treatment adherence. Active research staff out-
reach promoted engagement and retention in the trial. Treatment satisfaction
was rated as very good. In both observed and multiple imputation results, women
who received mCBT demonstrated greater improvement in depressed mood than
those in TAU at 16-week post-randomization and 3-month follow-up, Cohen’s
d = –0.71 (95% CI –4.93, –5.70). Conclusions: Modified CBT offers promise
as a feasible and acceptable treatment for perinatal women with low-incomes in
prenatal care settings. Targeted delivery and content modifications are needed to
engage populations tailored to setting and psychosocial challenges specific to the
perinatal period. Depression and Anxiety 30:679–687, 2013. C© 2013 Wiley
Periodicals, Inc.
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INTRODUCTION
Depression during the perinatal period is a signiﬁ-
cant public health problem. Rates of depression peak
during the childbearing years. Approximately, 12.8%
of women will suffer from depression prenatally, 9.9%
postnatally.[1,2] The impact of perinatal depression is
substantial, affecting both mother and child.[3,4] Despite
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this impact, less than half of women suffering from peri-
natal depression will receive mental health treatment.[5]
Low-income women are particularly unlikely to receive
treatment[6] despite their higher rates of depression.[7]
Among perinatal women, this disparity is troubling given
that a low-income status intensiﬁes the negative effects
of maternal depression on child outcomes.[8,9] There is
consequently a signiﬁcant need to improve access to ef-
fective and acceptable interventions for perinatal depres-
sion, especially for low-income women.
Cognitive behavioral therapy (CBT) is an empiri-
cally supported treatment for major depressive disorder
(MDD). In meta-analyses, it has a moderate between-
group effect sizes (CBT: effect size= 0.68[10]). However,
CBT for perinatal depression has a small effect size (ef-
fect size = 0.36;[10] effect size = 0.40[11]), and its uptake
among women with low incomes has been low,[12] sug-
gesting further development and research of CBT for
low-income women with perinatal depression is needed.
Effect sizes for CBT during the perinatal period may
be due to variation in the content and purity of the
intervention, study population, and women’s access to
treatment. To date, 10 trials of individual CBT for peri-
natal depression have been conducted. Two of these
targeted perinatal women with low incomes.[12,13] Of
these, one study found a reduction in depressive symp-
toms in women who received a CBT-oriented treatment
compared with a nonrandomized comparison group.[13]
The other, a randomized controlled trial (RCT) of a
multicomponent treatment that included CBT, had low
rates of adherence, and failed to ﬁnd statistically sig-
niﬁcant differences in outcomes between women in the
CBT and control groups.[12] Other trials were of brief
CBT(one to six sessions[14–16]),CBT informed strategies
provided in combination with other approaches (e.g.,
psychodynamic;[17] pharmacological[18]), and trials that
did not deﬁne depression in terms of clinical diagnostic
criteria.[16,19,20]
Two recent RCTs have found that group CBT can
be effectively delivered to racial minority or low-income
women at risk for perinatal depression who do not meet
current diagnostic criteria for MDD.[21,22] However,
there is little research providing a comprehensive test
of the feasibility and acceptability of a CBT intervention
that is consistent with the essential components of CBT,
modiﬁed for the perinatal period, and delivered to low-
income women who are currently clinically depressed.
TREATMENT MODIFICATIONS: WHAT IS
NEEDED?
A growing body of research suggests that delivery
modiﬁcations are needed to improve treatment utiliza-
tion amongdepressedwomenwith low incomes. Psycho-
logical interventions forMDDthat have failed to address
both the practical and psychological barriers that women
with low incomes faced had low rates of adherence
(7–57%[12,23]). In contrast, studies that provided a
broader range of support reported adherence rates
between 68 and 77%.[23,24] Women with low in-
comes struggle with practical and psychological fac-
tors that may negatively impact on their ability to seek
treatment (e.g., multiple jobs, exclusive caregiving of
child(ren), and stigma related to depression and income
level).[6, 25,26] During the perinatal period, these factors
interact with perinatal speciﬁc treatment barriers that
span psychological, practical, and logistical arenas (e.g.,
lack of time, fear of child being taken away).[3,27,28] Ad-
dressing these factors in treatment deliverymay be key to
improving the feasibility and acceptability of treatment
for perinatal depression.
The current study was a pilot RCT of individual CBT
modiﬁed for delivery to a racially diverse, primarily low-
income sample of clinically depressed perinatal women
(mCBT) seeking prenatal care in obstetrics (OBs) clinics.
We aimed to examine the preliminary feasibility and ef-
fectiveness of mCBT compared with treatment as usual
(TAU). Because adherence and acceptability are impor-
tant factors in low-income populations, we also exam-




All procedures were approved by the University of Michigan Med-
ical School Institutional Review Board. Participants were 55 pregnant
womenwithMDDrecruited inOBs clinic settings whowere randomly
assigned tomCBT (n= 30) orTAU (n= 25). Since the perinatal period
can be unpredictable and busy, we sought to improve adherence to the
treatment by recruiting women in the latter stages of pregnancy when
prenatal care visits are more frequent, and continuing treatment deliv-
ery during the postpartum period. Postpartum, the treatment schedule
followed OB appointments wherever possible in order to better con-
nect mental health to OB care. Inclusion criteria were as follows: age
18 or older, 24 or more weeks pregnant, not currently receiving any
treatment for depression, andmeetingDiagnostic and StatisticalMan-
ual – IV (DSM-IV) criteria for MDD. Once randomized, use of other
treatments was allowed to vary per usual practice. Women were ex-
cluded if they did not speak English, did not plan to return to the clinic
for additional care (e.g., moving out of the area), suffered from a cog-
nitive disability or any psychotic disorder, or met criteria for current
alcohol/drug abuse or dependence.
Wemaximized recruitment of women with low incomes by recruit-
ing from ﬁve OBs clinics, four of which primarily serve women of low
income. Three of the clinics were part of a nonproﬁt organization
focused on treating underserved populations in urban settings. The
other two clinic sites were afﬁliated with a university hospital system,
one provided care primarily for women withMedicaid. Research assis-
tants approached women in clinic waiting rooms, and administered the
EdinburghPostnatalDepression scale (EPDS[29]) to pregnantwomen,
who gave written consent. Women meeting inclusion criteria were in-
vited to participate in a clinical interview that included a diagnostic
assessment for MDD. Women meeting criteria for MDD were ran-
domly assigned to treatment (mCBT) or TAU (see Fig. 1).
TREATMENTS
The mCBT intervention consisted of up to twelve 50-min individ-
ual sessions of CBT, adapted for the perinatal period. The delivery
methods and content of CBT were modiﬁed based on the results, a
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Figure 1. Consort Flow Diagram
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Phase IMedical ResearchCouncil (MRC)[30] qualitative studywe con-
ducted with 22 purposively sampled perinatal women.[31,32] Women
indicated they preferred to have the delivery modality (e.g., home,
clinic-based) and treatment content individualized for their particular
needs and stage of pregnancy (pregnant or postpartum; O’Mahen[32]).
The mCBT treatment manual was piloted with 11 perinatal women
(not included in the present analyses) and further reﬁned by masters
and doctoral level clinical psychologists and social workers with exper-
tise in CBT and perinatal depression.
The ﬁnal mCBT included an initial engagement session, which
integrated Motivational Interviewing (MI),[33,34] and three treatment
modules: Behavioral Activation[35] (BA), Cognitive Restructuring
(CR), Interpersonal Support (IS). The ﬁrst (engagement) session
consisted of: (1) an initial perinatal speciﬁc assessment; (2) CBT
conceptualization tailored to the woman’s individual treatment goals;
(3) psychoeducation about perinatal depression and psychotherapy;
and (4) engagement strategies to identify and alleviate potential
psychological and practical barriers. Throughout the engagement
session, MI was used at any point in the interaction that pertained to
behavior change, including ambivalence or motivation about behavior
change. Consistent with previous CBT recommendations,[36] women
proceeded to the BA module. Speciﬁc BA techniques included the
use of a functional analytical approach to develop an understanding
of behaviors that interfere with meaningful, goal-oriented behaviors
and included self-monitoring, identifying “depressed behaviors,” de-
veloping alternative goal-oriented behaviors, and scheduling. Because
mothers in the Phase I research described difﬁculties with balancing
activities, rather than inactivation per se, the treatment focused
on helping mothers achieve a balance in valued activities. Based
on their perinatal case conceptualization, women struggling with
depressive cognitions or interpersonal difﬁculties as core problem
areas also completed the CR module, modiﬁed to focus on perinatal
speciﬁc cognitions (e.g., rigid motherhood beliefs[32]) and/or the IS
module. The IS module conceptualized interpersonal problems in a
functional analytical framework consistent with CBT. The therapist
worked with the client to develop alternative interpersonal behaviors.
The mCBT manual also included an appendix with perinatal speciﬁc
materials and skills (e.g., labor and delivery, sleep) that could be used
as tools to support the work in the other modules. Each week women
were asked to complete either written or verbally agreed treatment
exercises in-between sessions.
We employed an active outreach strategy for women who cancelled
or missed therapy appointments. Therapists were encouraged to make
multiple phone calls, send letters, and visit women to improve adher-
ence. Because many of the women in our trial were in unstable living
situations, participants were asked to provide two additional contacts
with permission to contact these individuals should the woman is un-
reachable.
Masters and doctoral level social workers and psychologists (n =
4) with experience in CBT and/or treatment for perinatal depression
were trained to deliver the mCBT intervention to competence. Train-
ing consisted of: reading the mCBT manual, review and training in
key concepts with either the Principal Investigator or Clinical Su-
pervisor and coinvestigator, and completion of an initial participant
under close supervision. Therapist competence was assessed with the
Revised Cognitive Therapy Scale (CTS-R[37]). A randomly selected
10% of audiotaped cases were monitored for adherence to the treat-
ment by the clinical supervisor. Issues of nonadherence tomCBTwere
addressed in weekly clinical supervision (e.g., therapists were advised
how to refocus treatment to mCBT).
TREATMENT AS USUAL
Following the regular care that occurred in all clinics, women al-
located to TAU, and those women who did not meet criteria for the
trial, were given feedback about their depression status from an on-site
social worker, psychoeducational materials about perinatal depression,
and local referral information about psychotherapy and case manage-
ment. They continued to receive midwife/obstetrical care as normal.
Risk was assessed at each interview point. If a woman was identiﬁed as
being at risk for suicide, University of Michigan risk procedures were
followed.
MEASURES
At enrollment women were screened for symptoms of depression.
Eligible women completed additional measures at the baseline clinical
interview (when randomization occurred), posttreatment (16 weeks
postrandomization), and at 3-month follow-up posttreatment. The
baseline and follow-up assessments were carried out by a researcher
blind to treatment status (see consort diagram in Fig. 1).
Depression. We used the EPDS,[29] a 10-item scale, to screen
for depression.[38] We used a cut-off of 12 or greater for detecting
depression.[39]
Diagnostic status was assessed with the Structured Clinical Inter-
view for DSM-IV Axis 1 Disorders—Patient Edition (SCID-I[40]).
TheBeckDepression Inventory-II (BDI-II[41]) is a reliablemeasure
of mood with perinatal populations[42] and is frequently used in CBT
trials.[10] Continuous scores on the BDI-II were used as the primary
outcome measure.
Adherence. A measure of adherence (telephone calls, comple-
tion of homework) was completed at each session.[24] Clients com-
pleted open-ended questions assessing the applicability of mCBT, bar-
riers to mCBT participation, and satisfaction with mCBT (percent
scale 0–100). Women who dropped out from mCBT were asked to
complete an open-ended interview asking about their reasons for dis-
engaging. Responses were content coded.
Barriers. Weassessed practical, logistical, and psychological bar-
riers to help seeking using a 25-item measure[27] with a 5-point Likert
scale (“not at all” to “completely”).
Activation. We used the 25-item BA for depression scale
(BADS[43]) scale (α =0.82) to assess activation and avoidance behaviors
which may impact engagement, adherence, and outcome. The BADS
has four subscales, Activation (α = 0.76), Avoidance/Rumination (α =
0.86), Work/School Impairment (α = 0.70), and Social Impairment
(α = 0.79)[43,44] Higher scores are indicative of greater activation.
Sample Size. Wecalculated theminimum sample size to detect a
clinically meaningful difference in depressive symptoms (BDI) as sig-
niﬁcant at the 0.05 level, with a power of 0.8, n = 2(0.84 + 1.96)2
× (σ /δ.) Based on previous published data (BDI = 23, σ = 8.09[45]),
a difference (δ) of 6.5 points would take BDI scores below Dozois
et al.[46] cut-off of 17 on the BDI. The sample size required per con-
dition therefore was n = 15.7(8.09/6.5)2 = 24.3. We therefore aimed
to recruit at least 48 women into the trial.
RANDOMIZATION
A statistician computer generated random assignment block was
used. Interviewers were provided with an opaque, sealed envelope that
contained information about which condition the participant would be
assigned to. At the conclusion of the assessment, if the participant met
the inclusion criteria for the study, the interviewer opened the envelope
and revealed its information to the participant and interviewer.
STATISTICAL ANALYSIS
The mCBT and TAU conditions were compared on the baseline
measures at preintervention using Chi-square, Pearson correlations,
and t-test analyses on categorical and continuousmeasures. Chi-square
analyses were conducted to test for bias due to attrition. Intent-to-
treat analyses were ﬁrst conducted with observed data, then using
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TABLE 1. Demographics and clinical characteristics of
participants at baseline
mCBT TAU
n = 30 n = 25
Age
m(SD) 27.40 (5.32) 26.62 (6.01)
Range 19–39 18–43
Weeks pregnant 30.9 (4.16) 30.9 (3.62)
Number of pregnancies 3.5 (2.22) 4.04 (1.90)
Relationship status
Partnered % (n) 70.0(21) 64.0 (16)
Married 36.7(11) 24.0(6)
Cohabitating 26.7(8) 24.0(6)
Not living together 6.7(2) 8.0(2)
Race
African American 53.3 (16) 64.0 (16)
White 33.3 (10) 28.0 (7)
Asian 10.0 (3) 4.0 (1)
Other 3.3 (1) 4.0 (1)
Educational level
Below high school 23.3 (7) 24.0 (6)
High school 23.3 (7) 36.0 (9)
Some college 16.7 (5) 24.0 (6)
College graduate 23.3 (7) 8.0 (2)
Beyond college 13.3 (4) 8.0 (2)
Currently employed for pay 13.3 (4) 16.0 (4)
Health insurance 96.7 (29) 100.0 (25)
Private 43.4 (13) 44.0 (11)
Medicaid 56.6 (17) 56.0 (14)
Comorbid conditions
Panic disorder %(n) 16.7(5) 0(0)
Social phobia 10(3) 16(4)
Speciﬁc phobia 6.7(2) 4(1)
Obsessive compulsive disorder 10(3) 0(0)
Generalized anxiety disorder 10(3) 12(3)
Posttraumatic stress disorder 16(4) 12(3)
Income bracket % (n) (US $)a (n = 29) (n = 22)
<10,000 13.7 (4) 18.1 (4)
10,000–19,999 44.8 (13) 59.0 (13)
20,000–39,999 17.2 (5) 9.0 (2)
40,000–59,999 10.3 (3) 4.5 (1)
60,000–79,999 6.9 (2) 9.0 (2)
≥80,000 6.9 (2) n/a
mCBT, cognitive behavioral therapy modiﬁed; TAU, treatment as
usual.
aA subsample of women declined to respond to the family income
question.
multiple imputation by chained equations, using 50 imputations.[47]
The effects of study condition on posttest outcome measures were
examined using repeated measures Analysis of Covariance (AN-
COVA). Predictors of feasibility and acceptability were analyzed with
correlation, t-tests, and multiple regression. Alpha level was set to P <
.05 for all tests. Cohen’s d based on pooled standard deviationswas used
to calculate effect sizes. We used Jacobson and Truax’s[48] procedures
for calculating reliable and clinically signiﬁcant change to quantify
clinical improvement in depressive symptoms on the BDI-II. Because
multiple imputationmethods donot supply individual participant-level
data, we report last observation carried forward (LOCF) analyses as it
is likely to be a conservative analysis.[49]
RESULTS
BASELINE CHARACTERISTICS
Figure 1 describes the ﬂow of women through the
trial.Table 1 shows thebaseline characteristics ofwomen
in the trial, including racial minority representation
(African American 58%, n = 32/55) and anxiety comor-
bidity in the sample (44%, n = 24/55). There were no
signiﬁcant demographic or depression score differences
between groups in the mCBT versus TAU groups. Be-
cause the BADS subscale work/school impairment was
positively correlated with posttreatment (16-week pos-
trandomization) BDI-II scores, r(45) = .49, P = .05,
it was controlled for in primary analyses of depres-
sion outcomes (SCID and BDI-II).[50] There were no
other signiﬁcant relationships between any of the demo-
graphic variables and 16-week postrandomization BDI-
II scores or SCID MDD outcomes. There were signif-
icant between-group differences in attrition, χ2 (1) =
13.19, P = .001. A lower percent of individuals com-
pleted the 16-week postrandomization questionnaires in
the mCBT group (70%, n = 21/30) than in the control
group (84%, n = 21/25).
FEASIBILITY
Engagement and Adherence. In the treatment
group, 83% (n = 25/30) of women attended the ﬁrst ses-
sion; 72%engagedwith the treatment, deﬁned as attend-
ing the second session. Women who were more func-
tionally impaired in work and social domains, t (29) =
11.86, P = .002, and had higher EPDS scores at screen-
ing, t (29) = 4.53, P = .04, were less likely to attend
the ﬁrst session. There were no demographic or psy-
chological factors (avoidance, barriers) associated with
treatment engagement.
Figure 1 shows the number of sessions attended.
Women received an average of 2.30 (SD = 2.16) ses-
sions during pregnancy, and 5.35 (SD = 4.07) postpar-
tum. In TAU ﬁve women (17%) received psychotherapy
(m = 3.66, SD = 1.88).Seventy-three percent of ses-
sions were conducted in the participants’ homes, 12%
in the therapist’s ofﬁce, 8% in the OB clinic, 6% over
the phone, and 1% at a different location (e.g., homeless
shelter). Therapists called women approximately three
(SD = 2.34, range 0–9) times between each scheduled
therapy contact, and sessions were rescheduled on an
average of three times (SD = 1.11, range = 0–4). Sixty
percent of women (n = 18/30) were adherent with the
treatment, deﬁned as completing four or more (30%)
sessions, a number associated with improved symptoms
and functioning,[21,50,51] 43% (n = 13/30) completed
seven or more sessions. Women who were adherent had
lower 16-week postrandomization BDI-II scores, F(29)
= −7.14, P = .008. There were no demographic or psy-
chological variables (barriers, avoidance) associated with
adherence.Barriers to therapy adherence included strug-
glingwith the care demands of a newbaby, child illnesses,
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TABLE 2. Mean depression scores and frequency of cases above depression (BDI-II) threshold
Posttreatmenta (16 weeks 3 months
Baseline postrandomization) posttreatment
Intervention TAU Intervention TAU Intervention TAU
Depression
Mean BDI-II 29.93 (9.66) 26.56 (6.52) 15.85 (7.84) 22.24 (12.67) 14.54 (9.86) 19.71 (13.81)
Imputed scores n/a n/a 15.19 (2.12) 23.39 (2.31) 14.20 (2.20) 21.47 (2.40)
BDI-II ≥ 14 29 (96.7%) 25 (100%) 9 (65%) 15 (60%) 8 (44.4%) 14 (68.3%)
Imputed scores n/a n/a 15 (50%) 15 (60%) 15 (50%) 14 (56.7%)
BADS 70.65(22.22) 71.81(21.11) 88.63 (23.75) 81.09 (20.02)a n/a n/ab
BDI-II, Beck Depression Inventory-II; BADS, behavioral activation for depression scale; TAU, treatment as usual.
aPre–post between-group differences on the BADS for completers were F (1, 38) = 1.54, P = .22, multiple imputation, F (1, 51) = 9.85, P = .02.
bData on the BADS at 3 months was not available.
pregnancy-related pain, and housing concerns, and lack-
ing a private, safe home in which to meet.
Treatment Applicability and Satisfaction.
Women reported high levels of content applica-
bility in session-by-session assessments of mCBT
content (m = 2.92, SD = 0.67, range 1.67–4.00). They
also reported high rates of treatment satisfaction, (m
= 3.20, SD = 0.70, range 0.67–4.00). Satisfaction
was correlated with the applicability of the material,
r(28) = .80, P = .001. After controlling for mood at
baseline, treatment applicability was not related with
mood at posttreatment, r(18) = .09, P = .78, but greater
treatment satisfaction was negatively correlated with
EPDS scores, r(18) = .54, P = .03.
Treatment Nonadherence. Of the 12 women
who were nonadherent with mCBT, seven (58%) com-
pleted a disengagement interview. Women’s reasons
for nonadherence included the following: not liking
the session-by-session questionnaires, wanting more
practical advice from the therapist, feeling doubtful that
the therapist could “help withmy past,” not having time,
difﬁculties prioritizing self over family, and childcare
difﬁculties.
SYMPTOM REDUCTION
Table 2 reports the means and standard deviation
mood scores for women in the control and mCBT
groups. A repeated-measures ANCOVA observed anal-
ysis with BDI-II score at 16-week postrandomization
and 3-month follow-up as the repeatedmeasure revealed
that, after controlling for baseline depression (BDI-II)
and BADS work/school avoidance, women in mCBT
had a greater decrease in their depressive symptoms than
women in the control group at 16-week postrandomiza-
tion and 3-month follow-up, F (1, 32) = 6.27, P = .02
(see Fig. 2). Mean differences were greater at 16-week
postrandomization, −7.7, Cohen’s d = −0.71 (95% CI
−4.93, −5.70) than at 3-month follow-up, −5.17, Co-
hen’s d = −0.44 (95% CI −4.65, 5.21). These results
were replicated inmultiple imputation analyses, F (1, 51)
= 6.94, P = .01. Mean differences favored mCBT over
TAU at 16-week postrandomization = −4.54, Cohen’s
d = −3.79 (95%CI−4.70, 2.80), and at 3-month follow-
up = −7.27, Cohen’s d = −3.23 (95% CI −4.12, 2.24).1
At posttreatment (16 weeks postrandomization), ob-
served analyses indicated there was no difference be-
tween themCBT (n = 4/30, 13.3%) andTAU (n = 1/25,
4%) groups on reliable and clinically signiﬁcant change
(OR = 6.40, 95% CI: 0.65, 62.84). In LOCF analyses,
more women in the mCBT (n = 8/29, 27.58%) expe-
rienced reliable and clinically signiﬁcant change than
women in TAU (n = 1/25, 4%), (OR = 8.60, 95% CI
0.91, 10.460).
DISCUSSION
In this pilot RCT, we found that individual CBT
adapted for the perinatal period offered promise as a
feasible and effective intervention in a sample of mainly
low-income women with MDD. Our treatment adher-
ence rates (attending four or more sessions[50,51]) were
similar to other trials with depressed low-incomewomen
deﬁned by Levy and O’Hara as having “better” adher-
ence. Although treatment adherence was related with
a greater reduction in depression scores, larger trials
are needed to delineate the minimum number of ses-
sions needed to detect treatment effects. This is partic-
ularly important when working with difﬁcult-to-engage
populations where the expenses of outreach efforts are
weighed against number of treatment sessions and their
therapeutic effect.
Similar to other studies with low-incomewomen,[6,24]
we found that intensive outreach efforts and the abil-
ity to deliver treatments in ﬂexible times and locations
were critical to keeping women involved with mCBT.
Our outreach efforts included an initial engagement ses-
sion, multiple reminder phone calls, ﬂexible appoint-
ment rescheduling, and maintaining positive working
1We conducted similar analyses after removing the somatic items from
the BDI. The completer results were F(1,32) = 6.78, P = .01; multiple
imputation analyses were F(1, 51) = 6.91, P < .01. In analyses not
adjusting for the BADs work/school avoidance subscale, completer
analyses were F(1,32) = 2.86, P = .08, multiple imputation analyses
were F(1, 51) = 5.08, P = .03.
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Figure 2. Between-group change in depression score across posttreatment (16-week postrandomizaton) and 3-month follow-up.
relationships with other care providers and family mem-
bers who supported women’s involvement with the trial.
Despite these efforts, ﬁve women did not attend the ﬁrst
therapy/engagement session, and these women also did
not complete the outcome assessments. We observed
that these women had particular concerns around child
protection and stigma. The remaining attended an av-
erage of 7 of 12 therapy sessions. This ﬁnding sug-
gests that once women attend one session, they may be
likely to remain engaged with continuing outreach ef-
forts.Thus, althoughour overall rates of recruitment and
attrition to the treatment were comparable to other de-
pression treatment trials with low-income populations,
more work is needed on outreach methods to engage
women experiencing complex life circumstances, stigma,
and overall service disengagement.
The extent to which similar outreach efforts are
sustainable within health-care systems should be ad-
dressed in future studies. Notably, women in this study
reported high rates of session-by-session satisfaction
with mCBT. Satisfaction was associated with the
perceived applicability of mCBT to their lives and to
improvements in depression scores, suggesting mCBT
was an acceptable intervention. Embedding mCBT
in settings outside of specialty care (such as prenatal
care settings) appears promising, but this approach
also requires mental health providers available in the
setting to provide treatment in a ﬂexible fashion that
meets with the changing schedules of women with high
levels of social and economic stress. Further, treatment
adherence may be improved by offering practical
incentives for treatment adherence (e.g., food pantries,
diapers, and linking treatment with case management
services). The efforts involved in treating mothers with
low-income may be offset by the public health costs
associated with their untreated depression.[6]
Consistent with epidemiological studies of depres-
sion across the perinatal period, depression improved
in all women. In both observed and multiple imputation
analyses, however, depression scores improved more in
womenwho receivedmCBT compared with those in the
TAU group, and these effects were sustained at 3-month
follow-up (effect size = 0.61). These results were clini-
cally and reliably signiﬁcant in LOCF analyses, although
not signiﬁcant in observed analyses. However, this was a
small pilot trial, and the variability in the observed results
indicates caution in interpreting the results.[52]
In sum, the results of this study suggest that mCBT
is a feasible, acceptable treatment for low-income, racial
minority women suffering from SCID diagnostic MDD
identiﬁed in prenatal care settings.
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